1. Grundmann S, Ständer S. Chronic pruritus: clinics and treatment. Ann Dermatol. 2011. 23:1–11.
Article
2. Arican O. Mechanisms and treatment options of pruritus associated with systemic diseases: a review. Turkiye Klinikleri J Med Sci. 2004. 24:664–671.
3. Arican O. Pathophysiology, clinical presentation and management of pruritus. Turkderm. 2005. 39:88–97.
4. Dogramaci AC, Serarslan G. The prevalence of pruritus in Mustafa Kemal University Dermatology outpatient clinic during July 2008. Trakya Univ Tip Fak Derg. 2009. 26:137–140.
5. van Os-Medendorp H, Eland-de Kok PC, Grypdonck M, Bruijnzeel-Koomen CA, Ros WJ. Prevalence and predictors of psychosocial morbidity in patients with chronic pruritic skin diseases. J Eur Acad Dermatol Venereol. 2006. 20:810–817.
Article
6. Bilac C, Ermertcan AT, Bilac DB, Deveci A, Horasan GD. The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol. 2009. 75:551.
Article
7. Gurel MS, Yanik M, Simsek Z, Kati M, Karaman A. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol. 2005. 44:933–938.
Article
8. Lange S, Zschocke I, Seidenglanz K, Schiffler A, Zollinger A, Amon U, et al. Predictors of the quality of life in patients with atopic dermatitis. Dermatol Psychosom. 2000. 1:66–70.
Article
9. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med. 1994. 56:36–40.
Article
10. Duque MI, Yosipovitch G, Chan YH, Smith R, Levy P. Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. J Am Acad Dermatol. 2005. 53:504–508.
Article
11. Arican O. Measuring of quality of life in dermatological patients. Turkiye Klinikleri J Dermatol (Special Topics). 2009. 2:107–114.
12. Tessari G, Dalle Vedove C, Loschiavo C, Tessitore N, Rugiu C, Lupo A, et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol. 2009. 22:241–248.
13. Tol H, Atalay H, Guney I, Gokbel H, Altintepe L, Buyukbas S, et al. The effect of Gabapentin therapy on pruritus, quality of life, depression and sleep quality in pruritic hemodialysis patients. Trakya Univ Tip Fak Derg. 2010. 27:1–5.
14. Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008. 59:234–244.
Article
15. Aksu AE, Urer MS, Sabuncu I, Saracoglu ZN, Chren MM. Turkish version of Skindex-29. Int J Dermatol. 2007. 46:350–355.
Article
16. Kaufmann R, Bieber T, Helgesen AL, Andersen BL, Luger T, Poulin Y, et al. Multicentre investigator group. Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy. 2006. 61:375–381.
Article
17. Gieler U, Niemeier V, Brosig B, Kupfer J. Psychosomatic aspects of pruritus. Dermatol Psychosom. 2002. 3:6–13.
Article
18. Amatya B, Nordlind K. Focus groups in Swedish psoriatic patients with pruritus. J Dermatol. 2008. 35:1–5.
19. Zachariae R, Zachariae CO, Lei U, Pedersen AF. Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol. 2008. 88:121–127.
Article
20. Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol. 2009. 89:339–350.
Article
21. Reich A, Szepietowski JC, Wisnicka B, Pacan P. Does stress influence itching in psoriatic patients? Dermatol Psychosom. 2003. 4:151–155.
Article
22. Yalçin B, Tamer E, Toy GG, Oztaş P, Hayran M, Alli N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006. 45:672–676.
Article
23. Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Ständer S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol. 2006. 31:762–767.
Article
24. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol. 1990. 123:769–774.
Article
25. Radmanesh M, Shafiei S. Underlying psychopathologies of psychogenic pruritic disorders. Dermatol Psychosom. 2001. 2:130–133.
Article
26. Chrostowska-Plak D, Salomon J, Reich A, Szepietowski JC. Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm Venereol. 2009. 89:379–383.
Article
27. Reich A, Szepietowski JC, Wisnicka B, Pacan P. Does stress influence itching in psoriatic patients? Dermatol Psychosom. 2003. 4:151–155.
Article
28. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol. 2006. 154:719–725.
Article
29. Wittkowski A, Richards HL, Griffiths CE, Main CJ. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res. 2004. 57:195–200.
Article
30. Weisshaar E, Apfelbacher C, Jäger G, Zimmermann E, Bruckner T, Diepgen TL, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol. 2006. 155:957–964.
Article
31. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005. 60:1073–1078.
Article